Q2 2026
Released Aug 13, 2026, after the close
10-Q filed Aug 13, 2026, 44 days after period end · 0001193125-26-349323
Q2 2026 · 10-Q
Revenue$458.44K$458.44K +240.6% vs Q2 2025+145.2% vs Q1 2026
Net Income-$2.31M-$2.31M N/M vs Q2 2025N/M vs Q1 2026
EPS Diluted-$0.05-$0.05 N/M vs Q2 2025N/M vs Q1 2026
Operating Income-$2,541,189N/M
Operating Cash Flowderived-$1,920,049N/M
Free Cash Flowderived-$1,920,049N/M
Margins · derived
Operating margin-554.3%+2125.6 pt vs Q2 2025
Net margin-504.8%+1933.0 pt vs Q2 2025
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $458.44K | $134.60K | — | — |
| Net Income | -$2.31M | -$3.28M | -$2.63M | -$4.45M |
| EPS Diluted | -$0.05 | -$0.07 | -$0.05 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR